EGFR and cancer: A recent review article summarizes the potential resistant factors, including activation of EGFR (epidermal growth factor receptor), AKT and c-Jun oncogenic signaling pathways, autophagy, epithelial–mesenchymal transition (EMT), hypoxia, cancer stemness, dysregulation of the cell cycle, and apoptosis resistance.